ProfileGDS4718 / 208323_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 81% 71% 88% 84% 84% 77% 91% 85% 89% 84% 70% 72% 90% 87% 96% 90% 76% 97% 98% 89% 92% 84% 85% 86% 90% 83% 85% 90% 66% 89% 95% 91% 82% 85% 82% 81% 82% 89% 67% 84% 80% 91% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6212392
GSM549102patient 115, normal, homogenized [OPG study]7.9450781
GSM549104patient 119, normal, homogenized [OPG study]7.0350771
GSM549108patient 138, normal, homogenized [OPG study]8.7824688
GSM549119patient 077, normal, homogenized [OPG study]8.2361884
GSM549133patient 032, cancer, homogenized [OPG study]8.4456284
GSM549139patient 042, cancer, homogenized [OPG study]7.5563677
GSM549099patient 107, normal, homogenized [OPG study]9.252691
GSM549109patient 139, normal, homogenized [OPG study]8.3692785
GSM549110patient 046, normal, homogenized [OPG study]9.0591289
GSM549114patient 063, normal, homogenized [OPG study]8.4606984
GSM549122patient 082, normal, homogenized [OPG study]6.900970
GSM549134patient 033, cancer, homogenized [OPG study]7.0166272
GSM549136patient 036, cancer, homogenized [OPG study]9.2418890
GSM549140patient 044, cancer, homogenized [OPG study]8.7799787
GSM549111patient 047, normal, homogenized [OPG study]10.817696
GSM549113patient 057, normal, homogenized [OPG study]9.2915490
GSM549132patient 031, cancer, homogenized [OPG study]7.4163576
GSM549137patient 038, cancer, homogenized [OPG study]10.756697
GSM549142patient 047, cancer, homogenized [OPG study]11.035498
GSM549100patient 110, normal, homogenized [OPG study]8.9647289
GSM549107patient 135, normal, homogenized [OPG study]9.6062892
GSM549115patient 068, normal, homogenized [OPG study]8.5010784
GSM549116patient 072, normal, homogenized [OPG study]8.5380185
GSM549120patient 078, normal, homogenized [OPG study]8.6596486
GSM549131patient 030, cancer, homogenized [OPG study]9.2352490
GSM549118patient 074, normal, homogenized [OPG study]8.2248183
GSM549129patient 027, cancer, homogenized [OPG study]8.4719985
GSM549123patient 088, normal, homogenized [OPG study]9.2387390
GSM549124patient 006, cancer, homogenized [OPG study]6.5238966
GSM549126patient 015, cancer, homogenized [OPG study]8.9873589
GSM549128patient 025, cancer, homogenized [OPG study]10.316395
GSM549103patient 117, normal, homogenized [OPG study]9.272891
GSM549117patient 073, normal, homogenized [OPG study]8.1099382
GSM549138patient 041, cancer, homogenized [OPG study]8.4401285
GSM549141patient 045, cancer, homogenized [OPG study]8.2261882
GSM549130patient 028, cancer, homogenized [OPG study]7.9595881
GSM549101patient 111, normal, homogenized [OPG study]8.0921282
GSM549105patient 128, normal, homogenized [OPG study]8.9457889
GSM549106patient 134, normal, homogenized [OPG study]6.6378567
GSM549112patient 048, normal, homogenized [OPG study]8.3300584
GSM549125patient 011, cancer, homogenized [OPG study]7.8047680
GSM549127patient 024, cancer, homogenized [OPG study]9.2101991
GSM549135patient 035, cancer, homogenized [OPG study]6.2918662